all patients received unrestricted intravenous fluids. All patients also received intravenous and/or inhaled anesthetic agents as well as opioids and muscle relaxants; however, carbamazepine, mannitol, or other diuretics were not routinely administered.
At the UVA Medical Center, a protocol for monitoring fluid balance and detecting DI during the postoperative period has been well established. Briefly, patients are weighed daily (at the same time, using the same scale) and the specific gravity of their urine is checked every 4 hours. Although Foley catheters are not routinely inserted, fluid intake and output are carefully recorded, and patients are questioned regarding thirst. Blood glucose, serum electrolytes (including sodium, potassium, and calcium), and serum osmolarities are determined daily. Serum sodium and osmolarity may be evaluated more frequently as indicated. Hyperglycemia is always excluded as a cause of polyuria and hyponatremia.
For the purpose of this review, a patient was considered to have clinical evidence of DI if the diagnosis was noted on the discharge summary by the primary neuroendocrine team and if the patient had documented voluminous urine output (Ͼ 300 ml/hour) for more than 3 hours, with a specific gravity of less than 1.005. A rising serum sodium level is considered to be evidence of DI but is not required to make the diagnosis or to initiate treatment. Given that the majority of patients in the postoperative period following transsphenoidal surgery are awake and alert and have intact thirst mechanisms as well as adequate access to fluids, desmopressin is not routinely administered. Nevertheless, desmopressin treatment in patients with the diagnosis of DI was recorded in the database. Follow-up records from both the neurosurgery and endocrinology clinics (if available) were reviewed to determine whether any patient had persistent DI and the need for long-term treatment with desmopressin. Finally, any patient with preexisting DI was excluded from the review. Statistical analysis was performed using the z-test. A probability level less than 0.05 was considered significant.
Results
The clinical disease and pathological diagnosis for each patient in this review is presented in Table 1 . Of the 881 patients reviewed, 24 had preexisting DI and were excluded from the study. Of the remaining 857 patients, 157 (18.3%) had clinical evidence of DI during the immediate postoperative period. Diabetes insipidus was treated with desmopressin in 106 patients (12.4%) at some point during their hospitalization. Persistent DI requiring long-term treatment with desmopressin was noted in 17 patients (2%).
Among the 743 patients who had a pituitary adenoma and no preoperative DI, 516 (69.4%) had macroadenomas. Microadenomas were found in 227 patients (30.6%). Diabetes insipidus was more likely to be diagnosed in patients with microadenomas than in those with macroadenomas (21.6 compared with 14.3%, respectively; p = 0.018) and more likely to be treated with desmopressin (14.5 compared with 9.3%, respectively; p = 0.049). Adenoma size had no impact on the development of persistent DI (Table 2) .
Of the 857 patients without preoperative DI, 186 presented for repeated transsphenoidal procedures. A repeated operation did not increase the incidence of either postoperative DI (21% in patients who underwent repeated surgery compared with 17.6% in patients who did not, p = 0.34) or disease necessitating treatment with desmopressin (12 those without, p = 0.896). Furthermore, a repeated operation did not increase the incidence of persistent DI requiring long-term treatment with desmopressin (Table 3 ).
An intraoperative CSF leak was noted in 273 patients (31.8%) and was associated with an increased incidence of DI (33.3% in patients with a leak compared with 11.3% in those without, p Ͻ 0.001) as well as an increased need for treatment with desmopressin (22.7% in patients with a CSF leak compared with 7.5% in those without, p Ͻ 0.001). Patients with a CSF leak were also noted to have an increased incidence of persistent DI (4.4 compared with 0.9% in patients without, p Ͻ 0.002) requiring long-term desmopressin treatment. These data are summarized in Table 4 . Among the subgroup of patients with a pituitary adenoma (743 patients), a CSF leak was also associated with an increased incidence of DI (31.7% in patients with a leak compared with 10% in those without, p Ͻ 0.001) and an increased need for desmopressin treatment (20 compared with 6.9%, respectively; p Ͻ 0.001). Only four patients with a pituitary adenoma suffered persistent DI requiring long-term treatment with desmopressin. Three of these four patients had an intraoperative CSF leak, but this difference was not statistically significant.
Considering clinical disease and pathological diagnosis, patients presenting with a craniopharyngioma were more likely to have DI (62.1% in patients with craniopharyngioma compared with 18.3% in the entire study cohort, p Ͻ 0.001) and to be treated with desmopressin (58.6 compared with 12.4%, respectively; p Ͻ 0.001). Patients with a craniopharyngioma were also more likely to have persistent DI (31 compared with 2%, respectively; p Ͻ 0.001) requiring long-term desmopressin treatment. Although patients presenting with an RCC were more likely to have DI (38.7 compared with 18.3% in the entire study cohort, p Ͻ 0.009), in-hospital treatment with desmopressin failed to reach statistical significance (19.4 compared with 12.4% in the entire study cohort, p Ͻ 0.38). Nevertheless, patients with an RCC were more likely to have persistent DI (9.7 compared with 2% in the entire study cohort, p Ͻ 0.027) requiring long-term treatment with desmopressin. In a comparison of the entire cohort of 857 patients, we found that the specific type of pituitary adenoma does not appear to impact the incidence of DI. These data are summarized in Table 5 . The probability values, ORs, and 95% CIs were calculated based on a comparison between each disease group and the entire study cohort.
Among patients with a pituitary adenoma (743 patients), the type of pituitary tumor only affected the incidence of DI if the patient had CD; that is, patients with CD (180 patients) were more likely to have DI than other patients with pituitary adenomas (22.2 compared with 14.7%, respectively; p = 0.026) and more likely to be treated with desmopressin (16.1 compared with 9.2%, respectively; p = 0.013). This finding corresponds to an OR of 1.65 (95% CI 1.08-2.52) for the diagnosis of DI and an OR of 1.89 (95% CI 1.16-3.08) for desmopressin treatment. No effect on the incidence of long-term DI requiring persistent desmopressin treatment was seen in patients with CD.
Discussion
Antidiuretic hormone is a nonapeptide that is synthesized in the hypothalamic paraventricular and supraoptic nuclei. After its initial synthesis, the precursor hormone is transferred down axons through the hypothalamoneurohypophysial tract to the posterior pituitary. In the posterior pituitary, ADH undergoes final maturation to active hormone and is stored for future release. 30 Secretion of ADH is regulated primarily by plasma osmolarity, but other factors such as left atrial distention, circulating blood volume, exercise, and certain emotional states can also alter ADH release. The relative or absolute deficiency in ADH results in DI. After transsphenoidal surgery, DI can result from an interruption in the transport of ADH from the hypothalamus, impairment of ADH release from the posterior pituitary, or retrograde damage to the cell bodies in the hypothalamic nuclei. Thus, damage anywhere along the hypothalamus-pituitary axis can result in DI.
Our data revealed the overall incidence of transient DI to be 18.3%. If we include only patients who underwent surgery for removal of a pituitary adenoma, the incidence decreases to 16.6%. Approximately 67.5% of patients with clinical evidence of DI were treated at least once with desmopressin; that is, 12.4% of all patients and 10.9% of patients with pituitary tumors were treated with desmopressin at some point during hospitalization.
In a series of 1571 patients with pituitary adenomas, Hensen, et al., 14 reported an overall incidence of 31% for hypotonic polyuria, with approximately 80% of those patients receiving desmopressin. Postoperatively, 24% of all patients who had undergone transsphenoidal surgery were treated with desmopressin at least once. We are unable to explain completely the approximately twofold decrease in the incidence of DI and treatment with desmopressin observed in our series. It has been previously proposed that the incidence of DI postsurgery is inversely related to the experience of the surgeon; 4 however, the procedures in both studies were clearly performed by very experienced surgeons. Given that Hensen and colleagues reported data from December 1982 to December 1995 and that we reported those from 1995 to 2001, it is possible that the apparent decrease in the incidence of DI results from improvements in surgical technique from 1982 to 2001, including improvements in radiographic imaging, such as MR imaging.
Nevertheless, there is considerable variation regarding the reported incidence of transient DI. 4, 14, 19, 23, 25, 26, 29, 30, 32 The retrospective nature of most studies, including the present series, can confound results. Indeed, it is more likely that the apparent difference between our study and the one conducted by Hensen and associates 14 relates to differences in the definition of DI and the willingness to treat the disease with desmopressin. Perhaps the philosophy for initiating medical therapy is simply more strict at UVA. Given that the majority of postoperative patients are awake and alert and have intact thirst mechanisms as well as adequate access to fluids, the occurrence of significant volume depletion and hyperosmolarity is relatively uncommon. Consequently, desmopressin is administered only if there is a significant discrepancy in fluid intake and output, a rising serum sodium level (Ͼ 145 mEq/L), and an excessive urine output that significantly interferes with sleep. Indeed, our reluctance to treat early DI is based on our recognition that postoperative DI is most often transient and self-limited. Nevertheless, different centers may have widely varying criteria for the treatment of DI with desmopressin and thus comparisons may be difficult.
In contrast to the tremendous variation in the reported incidence of transient DI, most authors note fairly consistent results regarding the incidence of persistent DI, usually be-
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Diabetes insipidus and transsphenoidal surgery 451 tween 0.5 and 1.5%. 2, 4, 14, 29, 30, 32 In the present series, the overall incidence of persistent DI was 2% among all patients. When considering only those patients who had undergone surgery for removal of a pituitary adenoma, the incidence decreased to 0.68%. Given the extremely low incidence of persistent DI, our data underscore the fact that most DI is transient and self-limited. Practitioners should prevent the overtreatment of polyuria with desmopressin, especially in patients who can keep up with urinary losses through oral fluid intake. Excessive desmopressin treatment can result in hyponatremia and significant morbidity.
Interestingly, transient DI and consequent desmopressin treatment are significantly more common after transsphenoidal surgery in patients harboring microadenomas (Table 2). Some authors have shown that DI is more common after the resection of macroadenomas. 2, 14, 23 Olson and colleagues 23 have asserted that more extensive exploration of the gland and stalk may be required for successful resection of microadenomas, especially when a tumor is very small or does not appear on preoperative imaging. Increased manipulation of the stalk and gland may result in more damage, however, and thus an increased risk of DI. Ciric and associates 4 have also posited that DI following the resection of a microadenoma is commonly the result of stalk manipulations. In patients with a macroadenoma, the tumor effectively displaces the posterior pituitary and the stalk upward, often leaving it covered with a fibrous layer. 4, 23 This location and protective layer may protect the posterior pituitary and may further explain the increased incidence of DI after resection of a microadenoma.
It has also been posited that new routes and/or mechanisms of ADH delivery may have developed in patients with macroadenoma. 19 The loss of normal posterior pituitary tissue by an expanding intrasellar mass is well recognized by neurosurgeons. Indeed, the loss of lipid-laden pituicytes can appear as a loss of normal high signal intensity on T 1 -weighted MR images. 6 This is particularly apparent in patients with macroadenomas. Such patients may be less susceptible to stalk manipulations and aberrations in ADH secretion. In fact, surgery may actually relieve the chronic distortion of the neurohypophysial stalk, leading to a surge in ADH release. 19 A repeated operation did not result in the increased incidence of transient or persistent DI. We had originally hypothesized that multiple operations involving more manipulations of the stalk and posterior pituitary might cause more damage and an increased incidence of DI; however, this obviously did not occur. A carefully conducted repeated operation is no more likely to precipitate DI than a carefully conducted resection of an untreated tumor. Furthermore, it is important to remember that total hypophysectomy does not necessarily lead to permanent DI. 3 Thus, even when there is only a small amount of residual gland present after several resections, DI might not occur.
Another interesting finding is the high incidence of transient and persistent DI in patients who had an observable intraoperative CSF leak. Indeed, aside from having a craniopharyngioma, there is no other perioperative factor associated with a higher risk of DI. Although it is most likely that an intraoperative CSF leak may simply be a marker for a more aggressive resection involving more stalk manipulation, there may be other explanations. All patients in this series with an observable intraoperative CSF leak underwent placement of a fat graft. After fat is harvested from the patient's abdomen, it is bathed in chloramphenicol and swiped across cotton such that very small, yet visible, wisps of cotton cling to the fat. 18 The cotton is thought to engender a mild foreign body reaction that helps seal the leak. 18 In addition to helping seal the leak, this inflammatory process may also promote an increased risk of transient DI. Considering that other inflammatory processes such as meningitis 11 (including neonatal meningitis 5 ), abscess, 12 and tuberculosis 16 can all present with DI, the inflammatory process initiated by cotton and fat may directly result in an increased incidence of, at least, transient DI. In addition, perhaps chloramphenicol leaches from the fat graft and induces transient DI. Note, however, that there are absolutely no data to support a relationship between intrathecal chloramphenicol and DI. Regardless, a prospective study focused on the direct contribution of a fat graft to the development of DI would no doubt be interesting.
Patients with a craniopharyngioma and an RCC were more likely to experience both transient and persistent DI. The increased risk of DI after resection of a craniopharyngioma has been well documented in the literature. 7, 15, 22 In the present series, the overall incidence of new persistent DI was 31%. This rate is relatively low considering that many surgeons believe the complication is unavoidable if complete resection is attempted; however, some authors 7 have found a lower-than-expected incidence if the operation is performed by a more experienced surgeon. Nevertheless, our data underscore the advantages of the transsphenoidal approach over the transcranial approach, in which the incidence of DI is much higher. 22 It has been previously postulated that a craniopharyngioma and an RCC may represent two points on a spectrum of sellar and parasellar cysts. 13, 21 As such, it is not surprising that resection of these lesions is associated with an increased risk of both transient and persistent DI. In the present series, the observed rate of persistent DI after removal of an RCC was 9.7%, which is slightly higher than the rate in other series. 1, 9 Note, however, that a rate comparison among the three series (9.7 compared with 3.6 9 compared with 6.5% 1 ) is not statistically significant because of the small sample sizes and relatively low incidence of persistent DI. The surgical philosophy at the UVA Medical Center includes attempted radical resection as opposed to simple drainage for most cases. The advantage of this approach includes a decreased rate of recurrence. Nevertheless, any increased incidence of DI, should it become significant, may occur because of a difference in surgical philosophy. 21 Data from previous studies have shown an increased incidence of transient DI among patients with CD.
14 There are a number of possible explanations for this circumstance. First, CD is most often diagnosed through a variety of laboratory tests, including those indicating an elevated serum adrenocortical stimulating hormone level, elevated serum cortisol level with loss of diurnal variation, and increased urinary free cortisol level as well as the dexamethasonesuppression test. Often, patients with biochemical evidence of CD do not demonstrate a visible pituitary adenoma on formal intracranial imaging studies, including computerized tomography scanning or MR imaging. 24, 25 Just as patients with a microadenoma may require more extensive exploration of the sella, which involves greater manipulation of the gland and stalk and an increased potential for damage, pa-tients with CD and a hidden adenoma are equally at risk. This point has been made by others. 14, 23, 24 Indeed, the incidence of DI is greater in patients with CD and a microadenoma than in patients harboring a microadenoma alone (23.9 compared with 17.4%, respectively), although the study is not adequately powered for this difference to be statistically significant. Interestingly, the incidence of DI among patients with CD and a macroadenoma was greater than the overall incidence of DI among all patients with a macroadenoma alone. This circumstance indicates that other factors may also be at least partially responsible.
Cortisol can induce a decrease in the renal concentrating ability, 14, 20 and the consequent hypotonic polyuria may be misdiagnosed as DI. Additionally, impaired glucose tolerance or overt diabetes mellitus is commonly encountered in patients with CD. 31 Although meticulous glucose control was an essential part of the postoperative care in all patients, including those with CD, it is still possible in this retrospective study that glycosuria may occasionally have been misdiagnosed as DI.
Conclusions
Even with modern surgical techniques performed by an experienced surgeon, transient DI remains a common complication of transsphenoidal surgery. In contrast, persistent DI is relatively uncommon, especially in patients with pituitary adenomas. Patients with microadenomas and CD have an increased risk of suffering transient DI. This circumstance is likely caused by the more aggressive gland and stalk manipulations required during resection of the microadenoma as well as changes in sellar and parasellar anatomy in patients with macroadenomas. Patients with an observable intraoperative CSF leak have an increased risk of both transient and persistent DI. This increased incidence may simply be a marker of a more aggressive resection, although a direct inflammatory effect cannot be eliminated as a potential cause. Patients with a craniopharyngioma have an increased risk for both transient and persistent DI due to the invasive nature of these aggressive tumors and their intimate involvement with the pituitary stalk and the hypothalamus; however, our data demonstrate a lower-than-expected incidence, indicating that surgical experience may play a role in the avoidance of this complication. Rathke cleft cysts are also associated with an increased incidence of both transient and persistent DI.
